Feline injection-site sarcoma: ABCD guidelines on prevention and management
- PMID: 26101312
- PMCID: PMC11148925
- DOI: 10.1177/1098612X15588451
Feline injection-site sarcoma: ABCD guidelines on prevention and management
Abstract
Overview: In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sarcomas (mostly fibrosarcomas): so-called 'feline injection-site sarcomas' (FISSs). These develop at sites of previous vaccination or injection. They have characteristics that are distinct from those of fibrosarcomas in other areas and behave more aggressively. The rate of metastasis ranges from 10-28%.
Pathogenesis: The pathogenesis of these sarcomas is not yet definitively explained. However, chronic inflammatory reactions are considered the trigger for subsequent malignant transformation. Injections of long-acting drugs (such as glucocorticoids, and others) have been associated with sarcoma formation. Adjuvanted vaccines induce intense local inflammation and seem therefore to be particularly linked to the development of FISS. The risk is lower for modified-live and recombinant vaccines, but no vaccine is risk-free.
Treatment and prevention: Aggressive, radical excision is required to avoid tumour recurrence. The prognosis improves if additional radiotherapy and/or immunotherapy (such as recombinant feline IL-2) are used. For prevention, administration of any irritating substance should be avoided. Vaccination should be performed as often as necessary, but as infrequently as possible. Non-adjuvanted, modified-live or recombinant vaccines should be selected in preference to adjuvanted vaccines. Injections should be given at sites at which surgery would likely lead to a complete cure; the interscapular region should generally be avoided. Post-vaccination monitoring should be performed.
© Published by SAGE on behalf of ISFM and AAFP 2015.
Conflict of interest statement
The authors do not have any potential conflicts of interest to declare.
Figures






References
-
- Hendrick MJ, Dunagan CA. Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988–1989). J Am Vet Med Assoc 1991; 198: 304–305. - PubMed
-
- Hendrick MJ, Goldschmidt MH. Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 1991; 199: 968. - PubMed
-
- Kass PH, Barnes WG, Jr, Spangler WL, et al. . Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993; 203: 396–405. - PubMed
-
- Carroll EE, Dubielzig RR, Schultz RD. Cats differ from mink and ferrets in their response to commercial vaccines: a histologic comparison of early vaccine reactions. Vet Pathol 2002; 39: 216–227. - PubMed
-
- Munday JS, Stedman NL, Richey LJ. Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas. Vet Pathol 2003; 40: 288–293. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous